Evidence map›Paper›PMID 40986397›Full record

ArticleJournal of the American Society of Nephrology : JASN2025

Urinary Chemokines and the Continuing Challenge of Noninvasive Kidney Allograft Surveillance.

Syed Ali Husain, Krista L Lentine

Abstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Syed Ali HusainDepartment of Surgery, NYU Langone Health, New York, New York.ORCID 0000-0002-1823-0117
Krista L LentineSaint Louis University Transplant Center, SSM-Saint Louis University Hospital, St. Louis, Missouri.ORCID 0000-0002-9423-4849

Funding

Living Donor Extended Time Outcomes (LETO) StudyR01DK120551 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HSU, CHI-YUAN, LENTINE, KRISTA L · 2019 to 2023
$3.9M
Choosing Immune Suppression in Renal Transplantation by Efficacy and Morbidity2 (CISTEM2)R01DK139339 · NIDDK · WASHINGTON UNIVERSITY · PI David Adam Axelrod, Vikas R. Dharnidharka · 2024 to 2026
$1.9M
Using Decision Making Science to Optimize Deceased Donor Kidney AllocationK23DK133729 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HUSAIN, SYED ALI · 2022 to 2025
$678k
NIDDK NIH HHS K23 DK133729NIDDK NIH HHS K23DK133729NIDDK NIH HHS R01 DK120551NIDDK NIH HHS R01DK120551NIDDK NIH HHS R01 DK139339NIDDK NIH HHS R01DK139339
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

renal transplantationtransplantationtransplant outcomestransplant pathology

Identifiers

PMID40986397
PMCPMC12558681

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.